An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
NCT00042393 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS
Last updated 2014-01-07
Summary
The purpose of this early access protocol is to provide access to adefovir dipivoxil prior to its commercial availability to people with lamivudine-resistant chronic hepatitis B who have limited treatment options.
Conditions
Interventions
- DRUG
-
Adefovir Dipivoxil
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B
NCT00117676 ·Status: COMPLETED ·Phase: PHASE3
-
Tenofovir Disoproxil Fumarate (Tenofovir DF) Versus Emtricitabine/Tenofovir DF in Subjects Resistant to Lamivudine
NCT00737568 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B
NCT00071201 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B
NCT00095121 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil
NCT00307489 ·Status: COMPLETED ·Phase: PHASE2
-
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B
NCT00531167 ·Status: COMPLETED ·Phase: PHASE4
-
Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
NCT00158704 ·Status: TERMINATED ·Phase: NA
-
Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus Adefovir
NCT03236584 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials
NCT01337479 ·Status: COMPLETED
-
Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection
NCT00734162 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B
NCT00230503 ·Status: COMPLETED ·Phase: PHASE2
-
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies
NCT00142298 ·Status: COMPLETED ·Phase: PHASE3
-
Lamivudine and Adefovir Dipivoxil Fixed Dose Combination
NCT01353742 ·Status: COMPLETED ·Phase: PHASE1
-
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
NCT00704106 ·Status: COMPLETED
-
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
NCT00076336 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B
NCT00116805 ·Status: COMPLETED ·Phase: PHASE3
-
TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA
NCT01732367 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection
NCT00605384 ·Status: TERMINATED ·Phase: PHASE3
-
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis
NCT00347009 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials
NCT01438424 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV
NCT00645294 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients
NCT01436539 ·Status: UNKNOWN ·Phase: PHASE4
-
Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients
NCT01491295 ·Status: UNKNOWN ·Phase: PHASE4
-
Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT
NCT00230477 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks
NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4